India's Cipla has said in a filing with the Bombay Stock Exchange that it has completed a move forward with a joint venture in Algeria that will lead to the production of respiratory drugs there. In February, Cipla said that it was creating the JV with Biopharma and that the partners would invest up to $15 million to build a manufacturing plant there, The Economic Times reports. Story